ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,132
Screening encounters
4,910
Diagnostic referrals
935
Outstanding pathways
324

Screening pathway

  1. Screening4,910Encounters
  2. Positive finding1,695Documented findings
  3. Referral935Diagnostic referrals
  4. Follow-up1,117Diagnostic visits
  5. Outcome611Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0806 · EXP-0806Synthetic · Site B

Full participant history through 2027-01-11, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2027-01-08
  4. · Diagnostic referral · EXP-0806-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Barrier documented · Contact difficulty
  9. · Contact attempt · Unsuccessful
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · No high-grade lesion identified
  14. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-09-04
  15. · Follow-up disposition · Resolved · EXP-0806-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4132 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0233 · Expanded synthetic participant 0233Site C — Rural Outreach Programme
EXP-0235 · Expanded synthetic participant 0235Site E — Resource-Constrained Navigation Programme
EXP-0236 · Expanded synthetic participant 0236Site C — Rural Outreach Programme
EXP-0237 · Expanded synthetic participant 0237Site D — Community Engagement Programme
EXP-0238 · Expanded synthetic participant 0238Site D — Community Engagement Programme
EXP-0239 · Expanded synthetic participant 0239Site A — Urban Referral Hub
EXP-0240 · Expanded synthetic participant 0240Site B — Peri-Urban Access Programme
EXP-0242 · Expanded synthetic participant 0242Site D — Community Engagement Programme
EXP-0243 · Expanded synthetic participant 0243Site D — Community Engagement Programme
EXP-0245 · Expanded synthetic participant 0245Site C — Rural Outreach Programme
EXP-0246 · Expanded synthetic participant 0246Site C — Rural Outreach Programme
EXP-0247 · Expanded synthetic participant 0247Site C — Rural Outreach Programme
EXP-0248 · Expanded synthetic participant 0248Site E — Resource-Constrained Navigation Programme
EXP-0249 · Expanded synthetic participant 0249Site E — Resource-Constrained Navigation Programme
EXP-0250 · Expanded synthetic participant 0250Site C — Rural Outreach Programme
EXP-0251 · Expanded synthetic participant 0251Site A — Urban Referral Hub
EXP-0252 · Expanded synthetic participant 0252Site A — Urban Referral Hub
EXP-0253 · Expanded synthetic participant 0253Site D — Community Engagement Programme
EXP-0254 · Expanded synthetic participant 0254Site A — Urban Referral Hub
EXP-0255 · Expanded synthetic participant 0255Site A — Urban Referral Hub
EXP-0256 · Expanded synthetic participant 0256Site A — Urban Referral Hub
EXP-0258 · Expanded synthetic participant 0258Site A — Urban Referral Hub
EXP-0259 · Expanded synthetic participant 0259Site D — Community Engagement Programme
EXP-0260 · Expanded synthetic participant 0260Site E — Resource-Constrained Navigation Programme
EXP-0261 · Expanded synthetic participant 0261Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1866
HPV DNA
2356
Cytology
688

Navigation activity

Barrier documented
836
Contact attempt
1363
Navigation intervention
367
Diagnostic booking
1160
Diagnostic visit
1117

Documented barriers

Contact difficulty
266
Transport difficulty
277
Appointment coordination
293

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.